Yuki Kageyama to Prognosis
This is a "connection" page, showing publications Yuki Kageyama has written about Prognosis.
Connection Strength
0.382
-
STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-?-induced Apoptosis in Urothelial Cancer. Anticancer Res. 2024 May; 44(5):1925-1930.
Score: 0.119
-
Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma. Anticancer Res. 2022 Feb; 42(2):1131-1136.
Score: 0.102
-
Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab. Cancer Immunol Immunother. 2021 Mar; 70(3):657-665.
Score: 0.023
-
Contact with renal sinus is associated with poor prognosis in surgically treated pT1 clear cell renal cell carcinoma. Int J Urol. 2020 Aug; 27(8):657-662.
Score: 0.023
-
[Treatment results of radical nephrectomy for relatively confined small renal cell carcinoma--translumbar versus transabdominal approach]. Nihon Hinyokika Gakkai Zasshi. 1994 Apr; 85(4):599-603.
Score: 0.015
-
Young age as favorable prognostic factor for cancer-specific survival in localized renal cell carcinoma. Urology. 2011 Apr; 77(4):842-7.
Score: 0.012
-
[Result of treatment for advanced germ cell tumor in the last decade]. Nihon Hinyokika Gakkai Zasshi. 2010 Mar; 101(3):539-46.
Score: 0.011
-
Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study. BJU Int. 2009 Jul; 104(2):189-94.
Score: 0.010
-
Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases. J Urol. 2008 Aug; 180(2):618-21; discussion 621.
Score: 0.010
-
C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy. BJU Int. 2008 Apr; 101(8):978-81.
Score: 0.010
-
The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. BJU Int. 2007 Aug; 100(2):269-73.
Score: 0.009
-
Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract. BJU Int. 2006 Jun; 97(6):1322-6.
Score: 0.009
-
Prognostic significance of endothelial Per-Arnt-sim domain protein 1/hypoxia-inducible factor-2alpha expression in a subset of tumor associated macrophages in invasive bladder cancer. J Urol. 2004 Mar; 171(3):1080-4.
Score: 0.007
-
Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin Cancer Res. 2003 Nov 15; 9(15):5501-7.
Score: 0.007
-
Increased expression of sialyl-Lewis A correlates with poor survival in upper urinary tract urothelial cancer patients. Anticancer Res. 2003 Jul-Aug; 23(4):3441-6.
Score: 0.007
-
Significance of bladder neck involvement on progression in superficial bladder cancer. Eur Urol. 1998; 33(5):464-8.
Score: 0.005
-
[The clinical study of 23 cases in patients with bladder cancer over 85 years old]. Hinyokika Kiyo. 1989 Jul; 35(7):1141-4.
Score: 0.003